830 resultados para Approach to public health
Resumo:
Mode of access: Internet.
Resumo:
Mode of access: Internet.
Resumo:
"Previously issued under the same title by the Centers of Disease Control and PRevention of the U. S. Public Health Service, Atlanta, Georgia"--t.p. verso.
Resumo:
Mode of access: Internet.
Resumo:
Schuyler O. Bland, chairman.
Resumo:
Item 1070-M.
Resumo:
Mode of access: Internet.
Resumo:
"Reprinted August 1985."
Resumo:
Cover Title: Report of Local Public Health Resources
Resumo:
Objective: To examine new strategies which may be implemented to address the significant mental health and substance abuse problems of young people within the juvenile justice system. Method: Wide-ranging literature review of mental health problems within the juvenile justice population is given, illustrating the high prevalence of mental health problems within this cohort of young people. Reference is made to the differing demographics and agendas of the American justice system compared to that found in Australia. Results: It is suggested that new initiatives stemming from quality Australian studies are required in order to facilitate reform within adolescent forensic mental health. Psychiatrists need to be at the forefront of innovative policy delivery within the juvenile justice system. Conclusions: A transdisciplinary approach is required to meet the changing needs of young people within the juvenile justice system. Such a system of care recognizes that these young people and their families have multiple needs that cross traditional boundaries and a collaborative approach across agencies is essential at both the policy and practical level. Psychiatrists have an important role to play in the development of these services. A systemic process to address such needs is offered.
Resumo:
Pharmacogenomics promotes an understanding of the genetic basis for differences in efficacy or toxicity of drugs in different individuals. Implementation of the outcomes of pharmacogenomic research into clinical practice presents a number of difficulties for healthcare. This paper aims to highlight one of the Unique ethical challenges which pharmacogenomics presents for the utilisation of cost-effectiveness analysis by public health systems. This paper contends that pharmacogenomics provides a challenge to fundamental principles which underlie most systems for deciding which drugs should be publicly subsidised. Pharmacogenomics brings into focus the conflict between equality and utility in the context of using cost-effectiveness analysis to aid distribution of a limited national drug budget.
Grant's Application: It's time for a new approach to a public interest' exclusion from patentability